First US trial of varenicline for e-cigarette cessation shows positive results

Benjamin Toll, Ph.D., Lisa Fucito, Ph.D., and colleagues developed a clinical trial for e-cigarette cessation that was meant to mimic real-world conditions. Credit: Medical University of South Carolina The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say. Researchers from Yale Cancer Center and MUSC Hollings Cancer Center published the results of their clinical trial of varenicline to help adults to stop using e-cigarettes in the American Journal of Preventive Medicine on May 16. The results showed a significant disparity between Read More